SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-19-000457
Filing Date
2019-01-22
Accepted
2019-01-22 19:00:33
Documents
1
Period of Report
2019-01-17

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-43763.html 4  
1 PRIMARY DOCUMENT marketforms-43763.xml 4 3967
  Complete submission text file 0001214659-19-000457.txt   5377
Mailing Address C/O BIOMARIN PHARMACEUTICAL INC. 105 DIGITAL DRIVE NOVATO CA 94949
Business Address
FUCHS HENRY J (Reporting) CIK: 0001197355 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35921 | Film No.: 19536300

Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Issuer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations